Guillermina Lozano

37PUBLICATIONS
134CO-AUTHORS
Molecular targetsCancer diagnosisProteins and peptidesPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jun 16, 2026
The physiological relevance of downstream effectors of p53 activity.

|Jan 08, 2026
Elucidating cooperative genetic events in DCIS progression in mutant p53-driven breast cancer.

Rhiannon L Morrissey, Joy M McDaniel, Gilda P Chau

|Jun 02, 2025
Targeted Degradation of Mutant p53 Reverses the Pro-oncogenic Dominant-Negative Effect.

|Apr 27, 2025
Mutant p53 Gain of Function: Why Many See It, Why Some Do Not.

Guillermina Lozano, Carol Prives, Kanaga Sabapathy

|Feb 13, 2025
Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator.

Anna M Puzio-Kuter, Lizhong Xu, Mary Kate McBrayer

|Aug 30, 2024
Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer.

Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram

Pageof 7

Frequent Collaborators

9 joint publications

Yuan Qi

7 joint publications

Gilda P Chau

6 joint publications

Xiaoping Su

6 joint publications

Amanda R Wasylishen